Overview of Spastop
| Property | Description |
|---|---|
| Active ingredient | Otilonium Bromide |
| Form | Oral film-coated tablet |
| Pharmacological class | Antispasmodic agent (Spasmolytic) |
| Common function | Relieves smooth muscle spasms in the gut |
| Origin | Synthetic anticholinergic compound |
What is Spastop and Its Pharmacological Classification?
Spastop is the specific brand name for a medication whose active ingredient is Otilonium Bromide (OB), and it belongs to the high-level pharmacological class of antispasmodic agents, often called spasmolytics. This compound is a synthetic anticholinergic compound and a quaternary ammonium derivative whose primary pharmacological role is to act on the smooth muscles of the digestive tract.
The classification as a spasmolytic defines the drug's core function: to reduce involuntary contractions and spasms in muscle tissue. Otilonium Bromide is an established synthetic compound that specifically targets muscle overactivity, providing relief from the discomfort associated with spastic states. Research indicates that Otilonium Bromide helps relieve painful spasms by regulating the flow of signals and calcium ions in the muscle cells.
Otilonium Bromide: Composition, Form, and General Purpose
The medication is a single active ingredient product, consisting of Otilonium Bromide alongside standard pharmaceutical solid excipients, delivered as an oral film-coated tablet. The general therapeutic goal of Spastop is to help calm painful, excessive contractions and normalize the rhythmic activity of the lower intestinal tract muscles. A typical neutral use scenario involves taking the tablets to manage sudden onset abdominal cramping.
The function of the medicine is achieved because the active substance acts locally on the smooth muscle of the gastrointestinal wall, where it works to stabilize the muscle cells and reduce their capacity to contract excessively. Due to its chemical structure, Otilonium Bromide is poorly absorbed into the systemic circulation, which contributes to its specialized localized therapeutic effect within the gut. The medication has a targeted, local action in the digestive system, minimizing effects elsewhere.
Is Spastop a Selective Spasmolytic Agent?
Yes, Spastop is distinguished as a highly selective spasmolytic agent due to the active compound, Otilonium Bromide, being structurally engineered for poor systemic absorption. This feature is essential as it ensures that the medication remains concentrated primarily within the walls of the intestines, maximizing its therapeutic benefit where the spasms occur. By targeting the source of the spastic states within the digestive tract, Spastop serves as an established compound used to manage symptoms arising from the abnormal motility of the gut.
